These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17053456)

  • 1. Variant Creutzfeldt-Jacob disease - the availability of a screening test will be the beginning, not the end, of difficult transfusion-related issues.
    Sandler SG
    Curr Opin Hematol; 2006 Nov; 13(6):445-6. PubMed ID: 17053456
    [No Abstract]   [Full Text] [Related]  

  • 2. Creutzfeldt-Jakob disease and blood products: FDA policy.
    Fratantoni JC
    Biologicals; 1998 Jun; 26(2):133-4. PubMed ID: 9811520
    [No Abstract]   [Full Text] [Related]  

  • 3. New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
    Basu A
    Nepal Med Coll J; 2003 Jun; 5(1):51-2. PubMed ID: 16583978
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
    Grady GF; Vyas GN
    Biologicals; 2007 Apr; 35(2):75-7. PubMed ID: 17317213
    [No Abstract]   [Full Text] [Related]  

  • 5. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG; Drohan W
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract]   [Full Text] [Related]  

  • 6. [Variants of Creutzfeldt Jacob disease. Opinion of the Working Group on Blood of the Federal Ministry for Health and Social Security].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):1082-90. PubMed ID: 16160898
    [No Abstract]   [Full Text] [Related]  

  • 7. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion transmission of human prion diseases.
    Zou S; Fang CT; Schonberger LB
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bloody mess. New safeguards will cut supplies of a lifesaving resource.
    Sobel RK
    US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease.
    Brown P; Cervenáková L; Diringer H
    J Lab Clin Med; 2001 Jan; 137(1):5-13. PubMed ID: 11150018
    [No Abstract]   [Full Text] [Related]  

  • 11. Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion.
    Minor PD
    Vox Sang; 2004 Apr; 86(3):164-70. PubMed ID: 15078250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Creutzfeldt-Jakob disease transmitted in blood? Is the absence of evidence of risk evidence of the absence of risk?
    Ricketts MN
    CMAJ; 1997 Nov; 157(10):1367-70. PubMed ID: 9371066
    [No Abstract]   [Full Text] [Related]  

  • 13. Creutzfeld-Jakob disease: the Grace General Hospital experience.
    Pauls F; Hayes J; Read J
    Leadersh Health Serv; 1996; 5(6):42-3. PubMed ID: 10163983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
    Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
    Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.
    Brown P
    Haemophilia; 2007 Dec; 13 Suppl 5():33-40. PubMed ID: 18078395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modern landscape of transfusion-related iatrogenic Creutzfeldt-Jakob disease and blood screening tests.
    Brown P; Cervenakova L
    Curr Opin Hematol; 2004 Sep; 11(5):351-6. PubMed ID: 15666660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US blood ban underlines CJD fears.
    Wadman M
    Nature; 2001 Jul; 412(6842):7. PubMed ID: 11452271
    [No Abstract]   [Full Text] [Related]  

  • 18. Pressure grows over US blood ban.
    Goodman S
    Nature; 2001 Aug; 412(6846):467. PubMed ID: 11484010
    [No Abstract]   [Full Text] [Related]  

  • 19. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML; Ludlam CA
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucoreduction and variant Creutzfeldt-Jakob disease.
    Darabi K; Dzik WH; Stowell CP; Saito Y
    Transfus Med; 2005 Aug; 15(4):335. PubMed ID: 16101813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.